Jan 11, 2023 / 07:15PM GMT
Noah James Burhance - JPMorgan Chase & Co, Research Division - Research Analyst
It's my pleasure to introduce John and the Amyris team, and we'll do 20 minutes of presentation and then about 20 minutes of Q&A. So turning it over to you, John.
John G. Melo - Amyris, Inc. - President, CEO & Director
Great. Noah, thank you very much. I think I left some product in the back. So good morning to everyone. Great to have everybody here in the room and those listening on the outside, thank you. Appreciate that.
We are going to be making forward-looking statements. Here's a disclaimer regarding those statements. Again, we are Amyris. We are the science making our planet healthier. What that really means is we focus on using biotechnology to engineer microbes that take cheap sources of carbon and make high-value chemistry using fermentation. And we're the world leader in doing that as we'll share with you a little bit through our presentation.
We are remaking the world sustainable. Our real mission is we believe there's a way that most
Amyris Inc at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot